Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01235689
What this trial is testing

Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie (prior sponsor, Abbott) 252
Large-scale testing (Phase 3)Study completedNCT00427921
What this trial is testing

Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)

Who this might be right for
Crohn's Disease
Abbott 304
Testing effectiveness (Phase 2)Study completedNCT05372939
What this trial is testing

Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET)

Who this might be right for
Ulcerative Colitis
Applied Molecular Transport 51
Testing effectiveness (Phase 2)Study completedNCT05570006
What this trial is testing

Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06290934
What this trial is testing

Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Gilead Sciences 228
Large-scale testing (Phase 3)Active Not RecruitingNCT03466411
What this trial is testing

The Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Janssen Research & Development, LLC 1,409
Large-scale testing (Phase 3)Ended earlyNCT06570772
What this trial is testing

Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio

Who this might be right for
Ulcerative Colitis
Alvotech Swiss AG 301
Large-scale testing (Phase 3)Active Not RecruitingNCT03950232
What this trial is testing

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Pfizer 896
Testing effectiveness (Phase 2)Study completedNCT00102921
What this trial is testing

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Amgen 70
Large-scale testing (Phase 3)Study completedNCT04397263
What this trial is testing

Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohns Disease
Janssen Pharmaceutical K.K. 38
Testing effectiveness (Phase 2)Study completedNCT01393899
What this trial is testing

The Safety And Efficacy Of Maintenance Therapy With CP-690,550

Who this might be right for
Crohn's Disease
Pfizer 180
Large-scale testing (Phase 3)Study completedNCT00408629
What this trial is testing

Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abbott 518
Testing effectiveness (Phase 2)Active Not RecruitingNCT07035041
What this trial is testing

D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
UC - Ulcerative ColitisModerately to Severely Active Ulcerative Colitis
InventisBio Co., Ltd 120
Large-scale testing (Phase 3)Ended earlyNCT05470985
What this trial is testing

Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy

Who this might be right for
Crohn Disease
Bristol-Myers Squibb 5
Testing effectiveness (Phase 2)Study completedNCT00727324
What this trial is testing

Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AM-Pharma 22
Large-scale testing (Phase 3)Study completedNCT02425111
What this trial is testing

Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease

Who this might be right for
Crohn's Disease
Takeda 101
Post-approval studies (Phase 4)Study completedNCT01556672
What this trial is testing

Adalimumab-psoriasis and Small Bowel Lesions

Who this might be right for
Plaque PsoriasisCrohn's Disease
Innovaderm Research Inc. 100
Not applicableStudy completedNCT06589895
What this trial is testing

Correlation Between RISANKIZUMAB's Trough Levels, Clinical and Biological Remission in Moderate to Severe Crohn's Disease: a Retrospective Multicentric Study

Who this might be right for
Inflammatory Bowel Diseases
Centre Hospitalier Universitaire de Nīmes 40
Large-scale testing (Phase 3)Study completedNCT00487539
What this trial is testing

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 1,065
Testing effectiveness (Phase 2)Study completedNCT00042055
What this trial is testing

CP-461 for the Treatment of Crohn's Disease

Who this might be right for
Crohn's Disease
Astellas Pharma Inc 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation